المؤلفون: Araujo-Castro M; Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain & Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain., Biagetti B; Department of Endocrinology and Nutrition, Hospital Universitario Vall de Hebrón, CIBERER U747 (ISCIII), ENDO-ERN, Barcelona, Spain., Menéndez Torre E; Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias & Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain., Novoa-Testa I; Department of Endocrinology and Nutrition, Hospital Universitario de A Coruña, A Coruña, Spain., Cordido F; Department of Endocrinology and Nutrition, Hospital Universitario de A Coruña, A Coruña, Spain., Pascual-Corrales E; Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Madrid, Spain & Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain., Rodríguez Berrocal V; Department of Neurosurgery, Hospital Universitario Ramón y Cajal, Madrid, Spain., Guerrero-Pérez F; Department of Endocrinology and Nutrition, Hospital Universitario de Bellvitge, Cataluña L'Hospitalet de Llobregat, Spain., Vicente A; Department of Endocrinology and Nutrition, Hospital Universitario de Toledo, Toledo, Spain., Percovich Hualpa JC; Department of Endocrinology and Nutrition, Hospital Universitario Gregorio Marañón, Madrid, Spain., García-Centeno R; Department of Endocrinology and Nutrition, Hospital Universitario Gregorio Marañón, Madrid, Spain., González-Fernández L; Department of Endocrinology and Nutrition, Hospital Universitario Gregorio Marañón, Madrid, Spain., Ollero García MD; Department of Endocrinology and Nutrition, Hospital Universitario Navarra, Pamplona, Spain., Irigaray Echarri A; Department of Endocrinology and Nutrition, Hospital Universitario Navarra, Pamplona, Spain., Moure Rodríguez MD; Department Endocrinology and Nutrition, Hospital Universitario de Cruces, Bilbao, Spain., Novo-Rodríguez C; Department of Endocrinology and Nutrition, Hospital Universitario Virgen de las Nieves, Granada, Spain., Calatayud M; Department of Endocrinology and Nutrition, Hospital Universitario Doce de Octubre, Madrid, Spain., Villar-Taibo R; Department of Endocrinology and Nutrition, Hospital Universitario de Santiago de Compostela, Madrid, Spain., Bernabéu I; Department of Endocrinology and Nutrition, Hospital Universitario de Santiago de Compostela, Madrid, Spain., Alvarez-Escola C; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain., Benítez Valderrama P; Department of Endocrinology and Nutrition, Hospital Universitario La Paz, Madrid, Spain., Tenorio-Jiménez C; Department of Endocrinology and Nutrition, Hospital Universitario Virgen de las Nieves, Granada, Spain., Abellán Galiana P; Department of Endocrinology and Nutrition, Hospital General Universitario de Castellón, Castellón, Spain.; Department of Medicine and Surgery, Universidad Cardenal Herrera-CEU, CEU Universities, Castellón, Spain., Venegas E; Department of Endocrinology and Nutrition, Hospital Universitario Virgen del Rocío, Sevilla, Spain., González-Molero I; Endocrinology and Nutrition Department, Hospital Regional Universitario de Málaga, IBIMA Plataforma Bionand, Málaga, Spain., Iglesias P; Department of Endocrinology and Nutrition, Hospital Universitario Puerta de Hierro, Madrid, Spain., Blanco-Carrera C; Department of Endocrinology and Nutrition, Hospital Universitario Príncipe de Asturias, Madrid, Spain., Vidal-Ostos De Lara F; Department of Endocrinology and Nutrition, Hospital Universitario Príncipe de Asturias, Madrid, Spain., de Miguel Novoa P; Department of Endocrinology and Nutrition, Hospital Clínico San Carlos, Madrid, Spain., López Mezquita E; Department of Endocrinology and Nutrition, Hospital Universitario Clínico San Cecilio, Granada, Spain., Hanzu FA; Department of Endocrinology and Nutrition, Hospital Clinic de Barcelona, Barcelona, Spain., Aldecoa I; Biomedical Diagnostic Center, Department of Pathology, Hospital Clinic - University of Barcelona, Barcelona, Spain.; Neurological Tissue Bank of the Biobank, FCRB-IDIBAPS-Hospital Clinic Barcelona, Barcelona, Spain., Aznar S; Department of Endocrinology and Nutrition, Hospital Universitario De Albacete, Albacete, Spain., Lamas C; Department of Endocrinology and Nutrition, Hospital Universitario De Albacete, Albacete, Spain., Aulinas A; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, IR-SANT PAU, CIBERER U747 (ISCIII), Barcelona, Spain.; Department of Medicine, Universitat de Vic-Universitat Central de Catalunya, Vic, Spain., Asla Q; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, IR-SANT PAU, CIBERER U747 (ISCIII), Barcelona, Spain.; Department of Medicine, Universitat de Vic-Universitat Central de Catalunya, Vic, Spain., Gracia Gimeno P; Department of Endocrinology and Nutrition, Hospital Royo Villanova, Zaragoza, Spain., Recio-Córdova JM; Department of Endocrinology and Nutrition, Hospital Royo Villanova, Zaragoza, Spain., Avilés-Pérez MD; Department of Endocrinology and Nutrition, Hospital Universitario Clínico San Cecilio, Granada, Spain., Asensio-Wandosell D; Department of Endocrinology and Nutrition, Hospital Universitario Germans Trias i Pujol, Cataluña, Spain., Sampedro-Núñez M; Department of Endocrinology and Nutrition, Hospital Universitario La Princesa Madrid, Spain., Cámara R; Department of Endocrinology and Nutrition, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Paja Fano M; Department of Endocrinology and Nutrition, OSI Bilbao-Basurto, Hospital Universitario de Basurto & University of the Basque Country UPV/EHU, Bilbao, Spain., Ruz-Caracuel I; Department of Pathology, Hospital Universitario Ramón y Cajal, IRYCIS & CIBER Cáncer (CIBERONC), Madrid, Spain., Fajardo C; Department of Endocrinology and Nutrition, Hospital Universitario La Ribera, Valencia, Spain., Marazuela M; Department of Endocrinology and Nutrition, Hospital Universitario La Princesa Madrid, Spain., Puig-Domingo M; Department of Endocrinology and Nutrition, Hospital Universitario Germans Trias i Pujol, Cataluña, Spain.

المصدر: Endocrine-related cancer [Endocr Relat Cancer] 2024 May 27; Vol. 31 (7). Date of Electronic Publication: 2024 May 27 (Print Publication: 2024).

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Somatostatin*/analogs & derivatives , Somatostatin*/therapeutic use , Human Growth Hormone*/analogs & derivatives , Human Growth Hormone*/therapeutic use , Prolactin*/blood , Prolactin*/metabolism , Neuroendocrine Tumors*/drug therapy , Neuroendocrine Tumors*/metabolism , Acromegaly*/drug therapy , Acromegaly*/metabolism, Humans ; Male ; Female ; Middle Aged ; Adult ; Retrospective Studies ; Pituitary Neoplasms/drug therapy ; Pituitary Neoplasms/metabolism ; Aged ; Young Adult

المؤلفون: Pavel M; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.; Department of Medicine 1, Friedrich Alexander University Erlangen-Nuernberg, University Hospital Erlangen, Erlangen, Germany., Lahner H; Department of Endocrinology and Metabolism, University Hospital Essen, Essen, Germany., Hörsch D; Department of Gastroenterology/Endocrinology, Zentralklinik Bad Berka, Bad Berka, Germany., Rinke A; Department of Gastroenterology, University Hospital Gießen and Marburg, Marburg and Philipps University Marburg, Germany., Denecke T; Department of Radiology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Diagnostic and Interventional Radiology, University Medical Center Leipzig, Leipzig, Germany., Koch A; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany., Regnault B; Ipsen Pharma, Boulogne-Billancourt, France., Helbig D; Ipsen Pharma GmbH, München, Germany., Hoffmanns P; Ipsen Pharma GmbH, München, Germany., Raderer M; Medical University Vienna, Internal Medicine I, Division of Oncology, Vienna, Austria.

المصدر: The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. e643-e654.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Somatostatin*/*analogs & derivatives, Temozolomide*/pharmacology , Temozolomide*/therapeutic use , Temozolomide*/administration & dosage , Somatostatin*/therapeutic use , Somatostatin*/pharmacology , Somatostatin*/administration & dosage , Neuroendocrine Tumors*/drug therapy , Neuroendocrine Tumors*/pathology , Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/pathology , Peptides, Cyclic*/therapeutic use , Peptides, Cyclic*/pharmacology , Peptides, Cyclic*/administration & dosage , Intestinal Neoplasms*/drug therapy , Intestinal Neoplasms*/pathology, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Prospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Aged, 80 and over

المؤلفون: Ueki Y; Tokushima University Graduate School of Health Sciences, Tokushima, Japan., Otsuka H; Department of Medical Imaging/Nuclear Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. hideki.otsuka@tokushima-u.ac.jp., Otani T; Advance Radiation Research, Education and Management Center, Tokushima University, Tokushima, Japan., Kasai R; Department of Medical Imaging/Nuclear Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan., Otomi Y; Department of Radiology and Radiation Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan., Ikemitsu D; Department of Radiology, Tokushima University Hospital, Tokushima, Japan., Azane S; Department of Radiology, Tokushima University Hospital, Tokushima, Japan., Kunikane Y; Department of Radiology, Tokushima University Hospital, Tokushima, Japan., Bando T; Department of Radiology, Tokushima University Hospital, Tokushima, Japan., Matsuda N; Department of Radiology, Tokushima University Hospital, Tokushima, Japan., Okada Y; Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan., Takayama T; Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan., Harada M; Department of Radiology and Radiation Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.

المصدر: Japanese journal of radiology [Jpn J Radiol] 2024 May; Vol. 42 (5), pp. 519-535. Date of Electronic Publication: 2024 Feb 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Japan NLM ID: 101490689 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1867-108X (Electronic) Linking ISSN: 18671071 NLM ISO Abbreviation: Jpn J Radiol Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/diagnostic imaging , Neuroendocrine Tumors*/pathology , Neoplasm Staging* , Receptors, Somatostatin*/metabolism , Radiopharmaceuticals*, Somatostatin/*analogs & derivatives, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Tomography, Emission-Computed, Single-Photon/methods ; Retrospective Studies ; Aged, 80 and over

المؤلفون: Demeure MJ; From the Departments of Surgery., Giuliano P; Radiology., Forester J; From the Departments of Surgery., Zakry N; Pathology., Ulaner GA

المصدر: Clinical nuclear medicine [Clin Nucl Med] 2024 Jul 01; Vol. 49 (7), pp. 695-697. Date of Electronic Publication: 2024 May 15.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Lippincott Country of Publication: United States NLM ID: 7611109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-0229 (Electronic) Linking ISSN: 03639762 NLM ISO Abbreviation: Clin Nucl Med Subsets: MEDLINE

مواضيع طبية MeSH: Radiosurgery* , Neuroendocrine Tumors*/diagnostic imaging , Neuroendocrine Tumors*/surgery , Neuroendocrine Tumors*/pathology , Ileal Neoplasms*/diagnostic imaging , Ileal Neoplasms*/surgery , Ileal Neoplasms*/pathology , Somatostatin*/analogs & derivatives, Humans ; Male ; Adult ; Lymphatic Metastasis ; Retroperitoneal Neoplasms/diagnostic imaging ; Retroperitoneal Neoplasms/surgery ; Retroperitoneal Neoplasms/pathology ; Intraoperative Period ; Surgery, Computer-Assisted ; Positron Emission Tomography Computed Tomography

المؤلفون: van de Weijer T; Department of Radiology and Nuclear Medicine, ENETS Center of Excellence, Maastricht University Medical Center (MUMC+), P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands.; School of Nutrition and Translational Research in Metabolism (NUTRIM), University of Maastricht (UM), P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands., Bemer F; Department of Radiology and Nuclear Medicine, ENETS Center of Excellence, Maastricht University Medical Center (MUMC+), P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands., de Vos-Geelen J; Department of Medical Oncology, ENETS Center of Excellence, MUMC+, P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands.; School for Oncology and Reproduction (GROW), UM, P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands., Hermans B; Department of Medical Oncology, ENETS Center of Excellence, MUMC+, P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands.; School for Oncology and Reproduction (GROW), UM, P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands., Mitea C; Department of Radiology and Nuclear Medicine, ENETS Center of Excellence, Maastricht University Medical Center (MUMC+), P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands.; School for Oncology and Reproduction (GROW), UM, P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands., van der Pol JAJ; Department of Radiology and Nuclear Medicine, ENETS Center of Excellence, Maastricht University Medical Center (MUMC+), P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands.; School for Cardiovascular Diseases (CARIM), UM, P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands., Lodewick T; Department of Radiology and Nuclear Medicine, ENETS Center of Excellence, Maastricht University Medical Center (MUMC+), P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands., Wildberger JE; Department of Radiology and Nuclear Medicine, ENETS Center of Excellence, Maastricht University Medical Center (MUMC+), P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands.; School for Cardiovascular Diseases (CARIM), UM, P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands., Mottaghy FM; Department of Radiology and Nuclear Medicine, ENETS Center of Excellence, Maastricht University Medical Center (MUMC+), P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands. fmottaghy@ukaachen.de.; School for Oncology and Reproduction (GROW), UM, P. Debeylaan 25, P.O. Box 5800, 6202, 6229 HX, AZ, Maastricht, The Netherlands. fmottaghy@ukaachen.de.; Department of Nuclear Medicine, University Hospital RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany. fmottaghy@ukaachen.de.

المصدر: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (8), pp. 2420-2427. Date of Electronic Publication: 2024 Feb 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/diagnostic imaging , Neuroendocrine Tumors*/metabolism , Neuroendocrine Tumors*/drug therapy , Positron Emission Tomography Computed Tomography* , Octreotide*/analogs & derivatives , Octreotide*/pharmacokinetics , Somatostatin*/analogs & derivatives , Somatostatin*/pharmacokinetics , Organometallic Compounds*/pharmacokinetics, Humans ; Middle Aged ; Tissue Distribution ; Female ; Male ; Aged ; Adult ; Retrospective Studies ; Radiopharmaceuticals/pharmacokinetics ; Aged, 80 and over

المؤلفون: Dubois J; Department of Radiopharmacy, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.; Department of Radiopharmacy, Montpellier University Hospital, Montpellier University, Montpellier, France.; Cancer Research Institute of Montpellier (IRCM), University of Montpellier, Montpellier, France., Tosato G; Montpellier University Hospital, Montpellier University, Montpellier, France., Garrigue P; Department of Radiopharmacy, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France., Taieb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France., Guillet B; Department of Radiopharmacy, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France., Nail V; Department of Radiopharmacy, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.

المصدر: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Jun; Vol. 39 (5), pp. 381-389. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8852 (Electronic) Linking ISSN: 10849785 NLM ISO Abbreviation: Cancer Biother Radiopharm Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/radiotherapy , Neuroendocrine Tumors*/pathology , Neuroendocrine Tumors*/drug therapy , Lutetium*/adverse effects , Lutetium*/therapeutic use , Radiopharmaceuticals*/adverse effects , Radiopharmaceuticals*/therapeutic use , Radiopharmaceuticals*/administration & dosage , Somatostatin*/analogs & derivatives , Somatostatin*/adverse effects, Humans ; Retrospective Studies ; Female ; Male ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Radioisotopes

المؤلفون: Shiraishi K; Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan., Akai T; Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan., Tomita T; Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan., Hayashi R; Department of Clinical Oncology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan., Minamisaka T; Department of Pathology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan., Kuroda S; Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan.

المصدر: Neuropathology : official journal of the Japanese Society of Neuropathology [Neuropathology] 2024 Jun; Vol. 44 (3), pp. 247-251. Date of Electronic Publication: 2023 Dec 15.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9606526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1789 (Electronic) Linking ISSN: 09196544 NLM ISO Abbreviation: Neuropathology Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/pathology , Pancreatic Neoplasms*/drug therapy , Somatostatin*/analogs & derivatives , Neuroendocrine Tumors*/pathology , Pituitary Apoplexy*/pathology , Adenoma*/pathology , Adenoma*/drug therapy , Peptides, Cyclic*/administration & dosage, Humans ; Aged, 80 and over ; Male ; Pituitary Neoplasms/pathology ; Pituitary Neoplasms/drug therapy ; Antineoplastic Agents/therapeutic use

المؤلفون: Gao F; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China., Zhang Y; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China; Biomedical Engineering Department, Huazhong University of Science and Technology, Wuhan, China., Chen M; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China., Song Z; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China., Dong R; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China., Qiu S; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China., Shen C; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China., Huang X; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China., Geng H; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China., Cheng W; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China. Electronic address: chengweihua@circ.com.cn., Hu J; HTA Co., Ltd., CAEA Center of Excellence on Nuclear Technology Applications for Engineering and Industrialization of Radiopharmaceuticals, CNNC Engineering Research Center of Radiopharmaceuticals, Beijing, China. Electronic address: huji@circ.com.cn.

المصدر: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2024 Feb 01; Vol. 193, pp. 106671. Date of Electronic Publication: 2023 Dec 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE

مواضيع طبية MeSH: Somatostatin* , Neuroendocrine Tumors*/diagnostic imaging, Humans ; Mice ; Animals ; Receptors, Somatostatin/metabolism ; Radiopharmaceuticals/chemistry ; Tissue Distribution ; HEK293 Cells ; Positron-Emission Tomography/methods ; Fluorine Radioisotopes/chemistry ; Peptides/chemistry ; Cell Line, Tumor

المؤلفون: Ruggeri RM; Endocrinology Unit, Department of Human Pathology of Adulthood and Childhood DETEV, University of Messina, 98125, Messina, Italy. rmruggeri@unime.it., Aini I; Endocrinology Unit, Azienda Ospedaliera Universitaria Sassari, Sassari, Italy., Gay S; Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Grossrubatscher EM; Endocrine Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Mancini C; Unit of Andrology and Endocrinology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00189, Rome, Italy., Tarsitano MG; Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy., Zamponi V; Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy., Isidori AM; Policlinico Umberto I, Università Sapienza, Gruppo NETTARE, Rome, Italy., Colao A; Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.; UNESCO Chair 'Education for Health and Sustainable Development', Federico II University, Naples, Italy., Faggiano A; Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.

مؤلفون مشاركون: NIKE group

المصدر: Reviews in endocrine & metabolic disorders [Rev Endocr Metab Disord] 2024 Apr; Vol. 25 (2), pp. 383-398. Date of Electronic Publication: 2023 Dec 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 100940588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2606 (Electronic) Linking ISSN: 13899155 NLM ISO Abbreviation: Rev Endocr Metab Disord Subsets: MEDLINE

مواضيع طبية MeSH: Somatostatin*/therapeutic use , Neuroendocrine Tumors*/pathology, Male ; Female ; Humans ; Quality of Life ; Receptors, Somatostatin/metabolism

المؤلفون: Khan MS; Cardiff and Vale University Health Board, Cardiff, UK. KhanMS14@cardiff.ac.uk., Cook K; Cardiff and Vale University Health Board, Cardiff, UK., Weickert MO; The ARDEN NET Centre, ENETS Centre of Excellence, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK., Davies L; The ARDEN NET Centre, ENETS Centre of Excellence, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK., Pritchard DM; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Day M; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Shah T; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Hull D; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Caplin M; Royal Free London NHS Foundation Trust, London, UK., Back M; Royal Free London NHS Foundation Trust, London, UK., Pommie C; Ipsen, Boulogne-Billancourt, France., Higgs K; Ipsen, Slough, UK.

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Feb 29; Vol. 32 (3), pp. 199. Date of Electronic Publication: 2024 Feb 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Activities of Daily Living* , Neuroendocrine Tumors*/drug therapy , Peptides, Cyclic*, Somatostatin/*analogs & derivatives, Adult ; Humans ; Middle Aged ; Cross-Sectional Studies ; Patient Preference ; Quality of Life ; Hospitals ; United Kingdom